These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of peripheral and local administration of picrotoxin on the release of newly synthesized 3H-dopamine in the caudate nucleus of the cat. Cheramy A, Nieoullon A, Glowinski J. Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):31-7. PubMed ID: 870831 [Abstract] [Full Text] [Related]
3. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway. Olianas MC, De Montis GM, Mulas G, Tagliamonte A. Eur J Pharmacol; 1978 Jun 01; 49(3):233-41. PubMed ID: 566207 [No Abstract] [Full Text] [Related]
4. Effect of GABAergic drugs on dopamine catabolism in the nigrostriatal and mesolimbic dopaminergic pathways of the rat. Gundlach AL, Beart PM. J Pharm Pharmacol; 1981 Jan 01; 33(1):41-3. PubMed ID: 6114152 [No Abstract] [Full Text] [Related]
5. GABA in the caudate nucleus: a possible synaptic transmitter of interneurons. Spehlmann R, Norcross K, Grimmer EJ. Experientia; 1977 May 15; 33(5):623-5. PubMed ID: 193718 [No Abstract] [Full Text] [Related]
6. gamma-Aminobutyric acid: the essential mediator of behaviour triggered by neostriatally applied apomorphine and haloperidol. Cools AR, Janssen HJ. J Pharm Pharmacol; 1976 Jan 15; 28(1):70-4. PubMed ID: 6658 [No Abstract] [Full Text] [Related]
7. Interdependence of the nigrostriatal dopaminergic systems on the two sides of the brain in the cat. Nieoullon A, Cheramy A, Glowinski J. Science; 1977 Oct 28; 198(4315):416-8. PubMed ID: 910137 [Abstract] [Full Text] [Related]
8. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation. Bunney BS, Aghajanian GK. Res Publ Assoc Res Nerv Ment Dis; 1976 Oct 28; 55():249-67. PubMed ID: 826996 [No Abstract] [Full Text] [Related]
13. In vivo evidence for GABAergic control of serotonin release in the cat substantia nigra. Soubrié P, Montsatruc JL, Bourgoin S, Reisine T, Artaud F, Glowinski J. Eur J Pharmacol; 1981 Feb 19; 69(4):483-8. PubMed ID: 6166484 [Abstract] [Full Text] [Related]
14. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions. Sphelmann R. Trans Am Neurol Assoc; 1974 Feb 19; 99():255-7. PubMed ID: 4156892 [No Abstract] [Full Text] [Related]
15. Involvement of cortico-striatal "glutamatergic" neurons in the presynaptic control of dopamine release in the cat caudate nucleus. Chéramy A, Barbeito L, Romo R, Godeheu G, Glowinski J. Clin Neuropharmacol; 1986 Feb 19; 9 Suppl 4():500-2. PubMed ID: 3567956 [No Abstract] [Full Text] [Related]
17. The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual-probe microdialysis study in awake rats. Santiago M, Westerink BH. Eur J Pharmacol; 1992 Aug 25; 219(2):175-81. PubMed ID: 1330605 [Abstract] [Full Text] [Related]
18. Role of various amino acids on the modulation of dopamine release from nigro-striatal dopaminergic neurones. Giorguieff-Chesselet MF, Besson MJ, Cheramy A, Glowinski J. J Physiol (Paris); 1979 Aug 25; 75(6):611-3. PubMed ID: 547062 [Abstract] [Full Text] [Related]
19. GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum. Starr MS. Eur J Pharmacol; 1978 Apr 01; 48(3):325-8. PubMed ID: 639860 [Abstract] [Full Text] [Related]
20. Stimulating effects of gamma-hydroxybutyrate on dopamine release from the caudate nucleus and the substantia nigra of the cat. Chéramy A, Nieoullon A, Glowinski J. J Pharmacol Exp Ther; 1977 Nov 01; 203(2):283-93. PubMed ID: 909063 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]